Volume 12, Issue 7 (8-2014)                   IJRM 2014, 12(7): 453-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yavari M, Khodabandeh F, Tansaz M, Rouholamin S. A neuropsychiatric complication of oligomenorrhea according to iranian traditional medicine. IJRM 2014; 12 (7) :453-0
URL: http://ijrm.ir/article-1-566-en.html
A neuropsychiatric complication of oligomenorrhea according to iranian traditional medicine
Maryam Yavari1 , Faezeh Khodabandeh2 , Mojgan Tansaz1 , Safoura Rouholamin * 3
1- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Isfahan University of Medical Sciences, Isfahan, Iran
3- Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , s_rouholamin@med.mui.ac.ir
Abstract:   (2398 Views)
Oligomenorrhea, a prevalent disease with serious complications, has been declared in the Avicenna traditional medicine in detail. Avicenna in his famous book, Cannon of Medicine, presents a syndrome termed ‘uterine strangulation’, as a complication of menstrual bleeding cessation and lack of sexual satisfaction. We have explained this syndrome from both traditional and conventional medicine viewpoints to propose a new hypothesis for diagnosis and treatment of women with oligomenorrhea and systemic signs/symptoms admitting to clinics for further evaluation. This hypothesis definitely needs to be further assessed and confirmed by strong clinical trials.
Keywords: Iranian traditional medicine, Oligomenorrhea, Uterine strangulation, Menstruation Disturbances.
Full-Text [PDF 467 kb]   (797 Downloads) |   |   Full-Text (HTML)  (378 Views)  
Type of Study: Original Article |
References
1. Agarwal A, Venkat A. Questionnaire on menstrual disorders in adolescent girls in Singapore. J Pediatr Adolesc Gynecol 2009; 22: 365-371. [DOI:10.1016/j.jpag.2009.02.005]
2. Shahbazian N, Falahat F. Prevalence of Menstrual Disorders in Early Puberty. Scientific Medical Journal 2007; 53: 181-186.
3. Noroozi A, Tahmasebi R. Pattern of menstruation, Hirsutism and dysmenorrhea in students of Boushehr medical and Khalig-e-Fars universities, 2002-03. J Hormozgan Univ Med Sci 2004; 4: 209-203.
4. Arefi S. PCO prevalence in adolescents with menstrual irregularity. Med J Reprod Infertil 2001; 5: 62-57.
5. Wiksten-Almströmer M, Hirschberg AL, Hagenfeldt K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand 2008; 87: 1162-1168. [DOI:10.1080/00016340802478166]
6. Singh KB. Menstrual disorders in college students. Am J obstet Gynecol 1981; 140: 299-302. [DOI:10.1016/0002-9378(81)90277-5]
7. Bachman GA, Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. Am J obstet Gynecol 1982; 144: 98-102. [DOI:10.1016/0002-9378(82)90402-1]
8. Jonathan S, Berek F, Paoulo A. Berek & Novak's Gynecology. 14th Ed. Philadelphia, Lippincott Williams & Wilkins; 2007.
9. Campbell S, Monga ASH. Gynaecology by TEN TEACHERS. 17th Ed. London, Arnold; 2000.
10. Speroff L, Fritz MA, editors. Clinical Gynecologic Endocronology and infertility. 7th Ed. Philadelphia, A wolters kluwer company; 2005.
11. Matsumoto J, Hata T. Re-evaluation of secondary amenorrheic patients one year after initial diagnosis: a prospective study. J Nippon Med Sch 2004; 71: 63-68. [DOI:10.1272/jnms.71.63]
12. Deligeoroglou E, Athanasopoulos N, Tsimaris P, Dimopoulos KD, Vrachnis N, Creatsas G. Evaluation and management of adolescent amenorrhea. Ann N Y Acad Sci 2010; 1205: 23-32. [DOI:10.1111/j.1749-6632.2010.05669.x]
13. Devoto E, Aravena L, Gaete X. Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine. Rev Med Chil 1998; 126: 943-951.
14. Gordley LB, Lemasters G, Simpson SR, Yiin JH. Menstrual disorders and occupational, stress, and racial factors among military personnel. J Occup Environ Med 2000; 42: 871-881. [DOI:10.1097/00043764-200009000-00005]
15. Lin HT, Lin LC, Shiao JS. The impact of self-perceived job stress on menstrual patterns among Taiwanese nurses. Ind Health 2007; 45: 709-714. [DOI:10.2486/indhealth.45.709]
16. Chung FF, Yao CC, Wan GH. The associations between menstrual function and life style/working conditions among nurses in Taiwan. J Occup Health 2005; 47: 149-156. [DOI:10.1539/joh.47.149]
17. Carr-Nangle RE, Johnson WG, Bergeron KC, Nangle DW. Body image changes over the menstrual cycle in normal women. Int J Eat Disord 1994; 16: 267-273. https://doi.org/10.1002/1098-108X(199411)16:3<267::AID-EAT2260160307>3.0.CO;2-Y [DOI:10.1002/1098-108X(199411)16:33.0.CO;2-Y]
18. Mokabberi Nezhad R, Zafarghandi N. Etiology and Semiology of Amenorrhea in the Traditional Iranian Medicine. J Islam Iran Trad Med 2012; 3: 19-30.
19. Arzani, M. Akbari medicine. First print. Qom, Institute of Natural Medicine's Revival, Jalaledin Pub; 2009.
20. Kermani N. Sharḥ al-asbāb wa-al-'alāmāt. Qom: Mu'assasat Iḥyā' Ṭibb Ṭabī'ī, Jalaledin Pub; 2008.
21. Ibn-e-sina (Avicenna Husain). Al-Qanun fit-tib [The Canon of Medicine], research of ebrahim shamsedine. Lebanon, Alaalami Beirut library Press; 2005.
22. Choopani R, Emtiazi M, Tansaz M, Khodadoost M. Semiology and Diagnosis in Iranian Traditional Medicine. Tehran, Farazandish Sabz Pub; 2009.
23. Al-ahwazi A. Kamel al-sanae al-tibb. Qom, Institute of Natural Medicine's Revival, Jalal-aldin Pub; 2007.
24. Sommer B. Stress and menstrual distress. J Human Stress 1978; 4: 5-10, 41-47. [DOI:10.1080/0097840X.1978.9934989]
25. Collins A, Eneroth P, Landgren BM. Psychoneuroendocrine stress responses and mood as related to the menstrual cycle. Psychosom Med 1985; 47: 512-527. [DOI:10.1097/00006842-198511000-00002]
26. Kramer MS. Menstrual epileptoid psychosis in an adolescent girl. Am J Dis Child 1977; 131: 316-317. [DOI:10.1001/archpedi.1977.02120160070012]
27. Gregory BA. The menstrual cycle and its disorders in psychiatric patients I. Review of the literature. J Psychosom Res 1957; 2: 61-79. [DOI:10.1016/0022-3999(75)90007-0]
28. Gregory BA. The menstrual cycle and its disorders in psychiatric patients II. J Psychosom Res 1957; 2: 199-224. [DOI:10.1016/0022-3999(57)90004-1]
29. Mordecai KL, Rubin LH, Maki PM. Effects of menstrual cycle phase and oral contraceptive use on verbal memory. Horm Behav 2008; 54: 286-293. [DOI:10.1016/j.yhbeh.2008.03.006]
30. Swerdlow NR, Hartman PL, Auerbach PP. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 1997; 41: 452-460. [DOI:10.1016/S0006-3223(96)00065-0]
31. Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003; 74: 299-304. [DOI:10.1016/S0165-0327(02)00117-9]
32. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009; 91: 207-212. [DOI:10.1016/j.fertnstert.2007.11.022]
33. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipol Disorders 2003: 5: 48-52. [DOI:10.1034/j.1399-5618.2003.00010.x]
34. Magharious W, Goff DC, Amico E. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Res 1998; 77: 159-166. [DOI:10.1016/S0165-1781(97)00137-6]
35. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 2010; 51: 599-602. [DOI:10.1016/j.comppsych.2010.02.009]
36. Joffe H, Hayes FJ. Hayes. Menstrual Cycle Dysfunction Associated with Neurologic and Psychiatric Disorders. Ann NY Acad Sci 2008; 1135: 219-229. [DOI:10.1196/annals.1429.030]
37. Dokras A. Mood and anxiety disorders in women with PCOS. Steroids 2012; 77: 338-341. [DOI:10.1016/j.steroids.2011.12.008]
38. Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM, et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988; 29: 612-619. [DOI:10.1111/j.1528-1157.1988.tb03770.x]
39. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43: 341-346. [DOI:10.1001/archneur.1986.00520040029014]
40. Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab 2001; 86: 2950-2956. [DOI:10.1210/jcem.86.7.7633]
41. Meo R, Bilo L. Polycystic ovary syndrome and epilepsy: a review of the evidence. Drugs 2003; 63: 1185-1227. [DOI:10.2165/00003495-200363120-00002]
42. Bilo L, Meo R. Epilepsy and polycystic ovary syndrome: where is the link? Neuro Sci 2006; 27: 221-230. [DOI:10.1007/s10072-006-0675-y]
43. Yutzy S, Parish B. Somatoform Disorders. 5th Edition. Arlington, American Psychiatric Publishing Inc.; 2008. [DOI:10.1002/9780470515167.ch74]
44. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed.Washington DC, American Psychiatric Association; 2000.
45. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93: 2421-2423. [DOI:10.1016/j.fertnstert.2009.09.018]
46. Jedel E, Waern M, Gustafson D, Lande´n M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod 2010; 25: 450-456. [DOI:10.1093/humrep/dep384]
47. Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an Internet-based survey in Germany. Hum Reprod 2009; 24: 1446-1451. [DOI:10.1093/humrep/dep031]
48. Mansson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landon M. Women with polycystic ovary syndrome are often depressed or anxious- a case control study. Psychoneuroendocrinology 2008; 33: 1132-1138. [DOI:10.1016/j.psyneuen.2008.06.003]
49. Sahingöz M, Uguz F, Gezginc K, Korucu DG. Axis I and Axis II diagnoses in women with PCOS. Gen Hosp Psychiatry 2013; 35: 508-511. [DOI:10.1016/j.genhosppsych.2013.04.003]
50. Dokras A, Clifton S, Futterweit W, Wild R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2012; 97: 225-230. [DOI:10.1016/j.fertnstert.2011.10.022]
51. Harmancı H, Hergüner S, Toy H. [Psychiatric symptoms in women with polycystic ovary syndrome]. Düşünen Adam 2013; 26: 157-163. (In Turkish)
52. Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801-5807. [DOI:10.1210/jc.2003-030562]
53. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006; 61: 723-732. [DOI:10.1097/01.ogx.0000243772.33357.84]
54. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005; 153: 853-860. [DOI:10.1530/eje.1.02024]
55. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-2286. [DOI:10.1093/humrep/dem108]
56. Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod 2008; 23: 2064-2071. [DOI:10.1093/humrep/den227]
57. Oddens BJ, den Tonkelaar I, Nieuwenhuyse H. Psychosocial experiences in women facing fertility problems- a comparative survey. Hum Reprod 1999; 14: 255-261. [DOI:10.1093/humrep/14.1.255]
58. Guerra D, Llobera A, Veiga A, Barri PN. Psychiatric morbidity in couples attending a fertility service. Hum Reprod 1998; 13: 1733-1736. [DOI:10.1093/humrep/13.6.1733]
59. Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010; 94: 1565-1574. [DOI:10.1016/j.fertnstert.2010.03.081]
60. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthycontrols. Psychom Med 2004; 66: 356-362.
61. Annagür BB, Tazegül A, Uguz F, Kerimoglu OS, Tekinarslan E, Celik C. Biological correlates of major depression and generalized anxiety disorder in women with polycystic ovary syndrome. J Psychosom Res 2013; 74: 244-247. [DOI:10.1016/j.jpsychores.2013.01.002]
62. Kartalcı Ş. Testosterone and depression. Psikiyatride Guncel Yaklasimlar-Current Approaches in Psychiatry 2010; 2.4: 457-472.
63. Kartalcı Ş, Özsoy S, Ünal S, Eşel E. Testosterone and 17-OH progesteron levels in women with depression and the effects of antidepressant treatment. Anat J Psychiatry 2010; 11: 285-292.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb